Vir Biotechnology, Inc.
Clinical trials sponsored by Vir Biotechnology, Inc., explained in plain language.
-
New hope for hepatitis b: experimental cocktails aim to silence the virus
Disease control CompletedThis early-stage study tested new drug combinations in 33 adults with chronic hepatitis B. The goal was to see if the treatments could lower the virus to undetectable levels and reduce a key marker of infection (HBsAg). While not a cure, the approach aims to better control the di…
Phase: PHASE1, PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
New hope for hepatitis b: experimental drug shows promise in early trial
Disease control CompletedThis study tested an experimental drug called VIR-2218, given alone or with another medicine (peginterferon), in 84 adults with chronic hepatitis B. The goal was to see if the drug is safe and can reduce the virus in the body. While it aims to control the infection, it is not exp…
Phase: PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated May 26, 2026 12:02 UTC